Start a free trial
Menu

STANAG 2563

STANAG 2563 and the civil-military medical interface doctrine

National authorities implementing NATO's civil-military medical interface doctrine, and defence suppliers whose contracts invoke AJMedP-6

STANAG 2563 is NATO's agreement committing member nations to implement AJMedP-6, the civil-military medical interface doctrine; it binds nations rather than suppliers, and the doctrine itself lives in AJMedP-6.

Edition
2
Published
2015-11-05

What it is

An agreement, not the doctrine itself

STANAG 2563 is a short covering agreement. The doctrine it exists for is AJMedP-6, Edition A, Allied joint civil-military medical interface doctrine, and the agreement's own aim is narrow: "to respond to the following interoperability requirements". Everything substantive - the principles, the planning guidance, the description of responsibilities - is in the publication, not the agreement.

That distinction is the thing readers most often have wrong about a STANAG. It is the instrument by which NATO nations commit to implement a standard. A nation ratifies it, implements it domestically, and a company meets it only because a contract or a tender says so. Ratification and implementation are separate steps, a nation can ratify with reservations, and so "is STANAG 2563 mandatory" has no general answer, only a contractual one.

What the doctrine is meant to achieve

The agreement states the doctrine's purpose in its own terms. It "should be applied by military medical forces, NATO as well as non-NATO, during operations involving non-military medical organizations", and it builds interoperability between nations in three ways: by outlining principles that govern military medical support at the interface with civilian populations, authorities and organizations; by providing guidance on the operational environment for concerted civilian and military medical planning; and by highlighting the responsibilities and medical capabilities available to a commander. None of that is elaborated here - it is AJMedP-6's content, described rather than reproduced on this page.

How a nation implements it

Ratification is examined by the nation and recorded in the NATO Standardization Document Database, and nations advise the NATO Standardization Office of their intention regarding implementation. Implementation itself is defined: the agreement "is implemented when the necessary orders/instructions have been issued directing the forces concerned to put the content of the covered standard into effect." Nations report effective implementation using the form in Annex H to AAP-03(J); partner nations use Annex G to the same publication. The agreement itself is reviewed at least once every three years, with the outcome recorded in the NSDD, and nations or NATO bodies may propose changes at any time through a standardization proposal, processed at the next review.

What it does not do

It describes no certification, no notified body, no government quality assurance and no audit of any organisation. Nations self-report their own ratification and implementation status; the only check the agreement names is of itself, through its own periodic review. It places no obligation on a supplier: nothing in the text addresses a manufacturer, a contractor or a product directly.

Edition and lineage

This is Edition 2, promulgated 5 November 2015. It supersedes STANAG 2563, Edition 1. It covers AJMedP-6, Edition A, and lists several related documents: STANAG 2437, which covers AJP-01, Allied joint doctrine; STANAG 2228, which covers AJP-4.10, Allied joint medical support doctrine; MC 326/3, NATO's principles and policies of medical support; ACO DIR 83-1, medical support to operations; and the UN-CMCoord Officer Field Handbook, a United Nations rather than a NATO document. None of the last three is in our catalogue.

How we help

There is no compliance work in STANAG 2563 itself for a company to map onto a platform, and the substance a supplier would actually need sits in AJMedP-6, not this covering agreement. Where the doctrine touches a defence supplier is usually indirect: a medical support element of a programme may expect people to be familiar with the civil-military interface principles the STANAG names, and what a customer can reasonably ask to see is the ordinary evidence that the expectation was met.

ComplyTrain holds that kind of evidence: the controlled procedures a medical, logistics or planning team works to, records of who has been trained on the doctrine a contract names, and the trail those generate. It does not write doctrine, plan civil-military coordination, or make a nation's ratification or implementation decision.

Which documents a given contract actually invokes, and what tier of requirement comes with them, is set by the contract and the customer's quality clause, never by us. The standards explorer shows what else sits alongside this agreement in the catalogue, and we are glad to talk through what a specific contract requires.

Standards it references

Questions

Does STANAG 2563 apply to my company?

Not by itself. It binds the nations that ratify it. A company encounters it, if at all, when a contract or a tender invokes AJMedP-6 or the civil-military medical doctrine it carries.

What is the difference between STANAG 2563 and AJMedP-6?

STANAG 2563 is the covering agreement; AJMedP-6 is the doctrine. The agreement commits nations to implement the publication, and the publication holds the principles, planning guidance and description of responsibilities.

Can a company be certified against STANAG 2563?

No. The agreement names no certification scheme, no notified body and no audit of an organisation. Its only stated check is a periodic review of the agreement itself, held at least every three years.

When is a nation considered to have implemented it?

When the necessary orders and instructions have been issued to the forces concerned, putting the content of AJMedP-6 into effect.

Which edition is current?

Edition 2, promulgated 5 November 2015, superseding Edition 1.